MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Bausch Health Cos Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

5.36 0.94

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

5.28

Max

5.47

Pagrindiniai rodikliai

By Trading Economics

Pajamos

190M

98M

Pardavimai

49M

2.6B

Pelnas, tenkantis vienai akcijai

1.16

Pelno marža

3.83

Darbuotojai

20,700

EBITDA

206M

853M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+50.55% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-04-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-595M

1.7B

Ankstesnė atidarymo kaina

4.42

Ankstesnė uždarymo kaina

5.36

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

Bausch Health Cos Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-04-22 13:12; UTC

Įsigijimai, susijungimai, perėmimai

Bausch Health Learns Icahn Has 34% Economic Interest in Shares

2024-10-17 23:57; UTC

Karštos akcijos

Stocks to Watch: Netflix, MGP Ingredients, Bausch Health

Akcijų palyginimas

Kainos pokytis

Bausch Health Cos Inc Prognozė

Kainos tikslas

By TipRanks

50.55% į viršų

12 mėnesių prognozė

Vidutinis 8.25 USD  50.55%

Aukščiausias 12 USD

Žemiausias 5 USD

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Bausch Health Cos Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

6 ratings

0

Pirkti

5

Laikyti

1

Parduoti

Techninis įvertinimas

By Trading Central

4.52 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bullish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Bausch Health Cos Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.